Correction to: MASCC guideline: cannabis for cancer‑related pain and risk of harms and adverse events

被引：0
|
作者：
Josephine To
Mellar Davis
Andrea Sbrana
Bryony Alderman
David Hui
Sandip Mukhopadhyay
Carole Bouleuc
Amy A. Case
Koji Amano
Gregory B. Crawford
Giulia de Feo
Kimberson Tanco
Jessica Garsed
机构：
[1] Northern Adelaide Local Health Network,Division of Aged Care, Rehabilitation and Palliative Care
[2] Geisinger Medical System,Palliative Care Department
[3] University of Pisa,Department of Palliative Care, Rehabilitation and Integrative Medicine
[4] Frimley Park Hospital,Department of Supportive and Palliative Care
[5] University of Texas MD Anderson Cancer Center,Division of Geriatrics and Palliative Medicine
[6] Indian Council of Medical Research,Department of Palliative Medicine
[7] P.S.L. University,Northern Adelaide Local Health Network, South Australia, Faculty of Health and Medical Sciences
[8] Institut Curie,undefined
[9] Roswell Park Comprehensive Cancer Center,undefined
[10] University at Buffalo Jacobs School of Medicine and Biomedical Sciences,undefined
[11] National Cancer Center Hospital,undefined
[12] University of Adelaide,undefined
[13] Instituto Nazionale Dei Tumori,undefined
[14] Geisinger Medical Center,undefined
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Low risk of anaesthetic-related adverse events in obstetric patients
    Reactions Weekly, 2021, 1874 (1) : 8 - 8
  • [42] Baseline risk factors associated with immune related adverse events and atezolizumab
    Madjar, Katrin
    Mohindra, Rajat
    Duran-Pacheco, Gonzalo
    Rasul, Rashad
    Essioux, Laurent
    Maiya, Vidya
    Chandler, G. Scott
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Disparities in cancer risk behaviors, cannabis use and adverse childhood experiences among cancer survivors
    Babatunde, Oluwole A.
    Jefferson, Melanie S.
    Adams, Swann
    Halbert, Chanita Hughes
    Osazuwa-Peters, Nosayaba
    Boakye, Eric Adjei
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [44] The Adverse Events of Oxycodone in Cancer-Related Pain A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ma, Hu
    Liu, Yuan
    Huang, Lang
    Zeng, Xian-Tao
    Jin, Su-Han
    Yue, Guo-Jun
    Tian, Xu
    Zhou, Jian-Guo
    MEDICINE, 2016, 95 (15)
  • [45] Risk Factors for Chemotherapy-Related Toxicity and Adverse Events in Elderly Thai Cancer Patients: A Prospective Study
    Phaibulvatanapong, Ekkamol
    Srinonprasert, Varalak
    Ithimakin, Suthinee
    ONCOLOGY, 2018, 94 (03) : 149 - 160
  • [46] Risk factors for stent-related adverse events in patients with obstructive colorectal cancer: Are we missing something?
    Fuccio, Lorenzo
    Cennamo, Vincenzo
    de Bellis, Mario
    GASTROINTESTINAL ENDOSCOPY, 2014, 80 (04) : 742 - 743
  • [47] Investigating the risk of severe adverse events in gabapentinoid users with chronic non-cancer pain in English primary care
    Gu, X.
    Chen, T. -C
    Steinke, D.
    Chen, L. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 3 - 3
  • [48] Identifying high risk patients for pain management strategies aimed at reducing postsurgical opioid-related adverse events.
    Nipper-Johnson, Kathy
    Minkowitz, Harold
    Scranton, Richard
    Shah, Manan
    Raju, Aditya
    Gruschkus, Stephen K.
    PHARMACOTHERAPY, 2013, 33 (10): : E243 - E243
  • [49] Rheumatic immune-related adverse events from cancer immunotherapy
    Leonard H. Calabrese
    Cassandra Calabrese
    Laura C. Cappelli
    Nature Reviews Rheumatology, 2018, 14 : 569 - 579
  • [50] Rheumatic immune-related adverse events from cancer immunotherapy
    Calabrese, Leonard H.
    Calabrese, Cassandra
    Cappelli, Laura C.
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (10) : 569 - 579
12345